ANTIMICROBIAL PHARMACOTHERAPY OF COMMUNITY-ACQUIRED PNEUMONIA IN LIVER CIRRHOSIS PATIENTS: ACCENT ON THE ANTIBIOTIC RESISTANCE RISK STRATIFICATION ArticleKobelevskaya N., Kudryashova Z.Journal of Global Pharma Technology. Vol. 12. 2020. P.. 104-110
PHARMACOGENETIC TESTING: EFFECTIVENESS OF THE USE OF THE INDIRECT ANTICOAGULANT WARFARIN ArticleBogaevskaya O., Batrakova I., Slyusar O., Talismanov V.Journal of Global Pharma Technology. Vol. 12. 2020. P.. 160-169
SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN PATIENTS AFTER MYOCARDIAL INFARCTION: PHARMACOEPIDEMIOLOGICAL STUDY ArticleBogaevskaya O., Ibragimova K., Bataev H., Gerasimova N., Afanaseva T.Journal of Global Pharma Technology. Vol. 12. 2020. P.. 353-361
STUDY OF THE SYSTEM OF CYTOKINES IN CASE OF HERPETIC AND CHLAMYDIA-HERPETIC INFECTION ArticleMarkelova E.V., Chepurnova N.S., Tulupova M.S., Karaulov A.V., Baibarina E.V., Mel'nikova Y.A., Shadrina M.N., Yakovleva Y., Rabota N.S., Ziangirova Y.V.Journal of Global Pharma Technology. Vol. 8. 2016. P.. 10-14
PROBLEMS OF ATOMIC SCIENCE AND TECHNOLOGY, SERIES THERMONUCLEAR FUSION JournalNational Research Center Kurchatov Institute.